Literature DB >> 19479167

Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson's disease. A National Survey of German neurologists in private practice.

Astrid Larisch1, Wolfgang H Oertel, Karla Eggert.   

Abstract

Although much progress has been made in the development of clinical practice guidelines (CPGs), there are few strategies for dissemination and implementation of these guidelines. This study examines the attitudes of neurologists to CPGs and barriers to CPG implementation, with a particular focus on the Parkinson's disease CPG (PD-CPG). A cross-sectional survey was performed in 2007 with a representative sample of 213 neurologists in private practice in Germany. The main outcome measures were the Tunis Attitudinal Scale and barrier assessment of CPGs. In addition, the awareness, applicability, and usefulness of the PD-CPG were assessed. Most of the neurologists agreed that CPGs are intended to improve the quality of care (82.2%; n = 171), are good educational tools (59.4%; n = 120), and are an unbiased synthesis of expert opinion (58.9%; n = 119). The main barriers to guideline implementation were lack of time (39.3%; n = 81), inability to reconcile patient preferences with guideline recommendations (34.3%; n = 71), and lack of awareness (32.5%; n = 67). A total of 187 (88.2%) of the neurologists were aware of the PD-CPG, of whom 163 (92.6%) found it "beneficial" and 173 (94.6%) applied it in daily practice. Nevertheless, only 51 (28.8%) of neurologists considered that the guidelines led to an improvement in the quality of care. However, 63 (32%) favored a special guideline for patients. Qualitative data analysis revealed more positive than negative aspects of the PD-CPG; positive comments included "treatment facilitation", "a stepped therapy schema" and "increasing self-efficacy". Criticism mostly concerned the lack of relevance to everyday practice and the rigidity of the guidelines. Neurologists in private practice have a generally positive attitude to guidelines. The PD-CPG is well-known and often used, but its impact on quality of care is considered to be only modest. Thus, further research is needed to address issues of daily practice in future versions of the PD-CPG and to investigate the effects of implementation at the physician and patient levels.

Entities:  

Mesh:

Year:  2009        PMID: 19479167     DOI: 10.1007/s00415-009-5178-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  30 in total

1.  Improving clinical practice guidelines for the 21st century. Attitudinal barriers and not technology are the main challenges.

Authors:  G P Browman
Journal:  Int J Technol Assess Health Care       Date:  2000       Impact factor: 2.188

Review 2.  Why don't physicians follow clinical practice guidelines? A framework for improvement.

Authors:  M D Cabana; C S Rand; N R Powe; A W Wu; M H Wilson; P A Abboud; H R Rubin
Journal:  JAMA       Date:  1999-10-20       Impact factor: 56.272

3.  Management of gastroesophageal reflux disease in primary care: results of a survey in 2 areas in Germany.

Authors:  A Meining; U Driesnack; M Classen; T Rösch
Journal:  Z Gastroenterol       Date:  2002-01       Impact factor: 2.000

Review 4.  Treatment of Parkinson's disease.

Authors: 
Journal:  Neurol Sci       Date:  2003-06       Impact factor: 3.307

5.  Awareness and knowledge of the clinical practice guideline on Parkinson's disease among German neurologists.

Authors:  Karla Eggert; Astrid Larisch; Richard Dodel; Cornelia Bormann; Wolfgang H Oertel
Journal:  Eur Neurol       Date:  2009-01-29       Impact factor: 1.710

6.  Clinical practice guidelines in general practice: a national survey of recall, attitudes and impact.

Authors:  L Gupta; J E Ward; R S Hayward
Journal:  Med J Aust       Date:  1997-01-20       Impact factor: 7.738

7.  Clinical practice guidelines: barriers to durability after effective early implementation.

Authors:  C Brand; F Landgren; A Hutchinson; C Jones; L Macgregor; D Campbell
Journal:  Intern Med J       Date:  2005-03       Impact factor: 2.048

8.  Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  O Suchowersky; S Reich; J Perlmutter; T Zesiewicz; G Gronseth; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

9.  Hypertension guidelines and their limitations--the impact of physicians' compliance as evaluated by guideline awareness.

Authors:  J Hagemeister; C A Schneider; S Barabas; R Schadt; G Wassmer; G Mager; H Pfaff; H W Höpp
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

10.  Internists' attitudes about clinical practice guidelines.

Authors:  S R Tunis; R S Hayward; M C Wilson; H R Rubin; E B Bass; M Johnston; E P Steinberg
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  13 in total

Review 1.  Parkinson's disease and 2009: recent advances.

Authors:  David P Breen; Roger A Barker
Journal:  J Neurol       Date:  2010-04-08       Impact factor: 4.849

2.  Barriers for the implementation of guidelines in palliative care-results from a national survey of professionals.

Authors:  Helen Kalies; Rieke Schöttmer; Steffen T Simon; Raymond Voltz; Alexander Crispin; Claudia Bausewein
Journal:  Support Care Cancer       Date:  2018-01-05       Impact factor: 3.603

3.  [Medical care of patients with spasticity following stroke : Evaluation of the treatment situation in Germany with focus on the use of botulinum toxin].

Authors:  L Kerkemeyer; G Lux; A Walendzik; J Wasem; A Neumann
Journal:  Nervenarzt       Date:  2017-08       Impact factor: 1.214

4.  Does the clinical practice guideline on Parkinson's disease change health outcomes? A cluster randomized controlled trial.

Authors:  Astrid Larisch; Alexander Reuss; Wolfgang H Oertel; Karla Eggert
Journal:  J Neurol       Date:  2010-12-07       Impact factor: 4.849

5.  Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia.

Authors:  Pille Taba; Marika Rosenthal; Jarno Habicht; Helvi Tarien; Mari Mathiesen; Suzanne Hill; Lisa Bero
Journal:  BMC Health Serv Res       Date:  2012-12-13       Impact factor: 2.655

6.  Do neurologists in Germany adhere to the national Parkinson's disease guideline?

Authors:  Sabrina Schröder; Daniel Kuessner; Guy Arnold; York Zöllner; Eddie Jones; Marion Schaefer
Journal:  Neuropsychiatr Dis Treat       Date:  2011-03-07       Impact factor: 2.570

7.  Physicians' attitudes toward, use of, and perceived barriers to clinical guidelines: a survey among Swiss physicians.

Authors:  Tanja Birrenbach; Simone Kraehenmann; Martin Perrig; Christoph Berendonk; Soeren Huwendiek
Journal:  Adv Med Educ Pract       Date:  2016-12-13

8.  Current clinical practice for Parkinson's disease among Chinese physicians, general neurologists and movement disorders specialists: a national survey.

Authors:  Wei Chen; Shuai Chen; Qin Xiao; Gang Wang; Sheng-Di Chen
Journal:  BMC Neurol       Date:  2012-12-07       Impact factor: 2.474

9.  A survey of attitudes to clinical practice guidelines in general and adherence of the Korea practical guidelines for management of gallbladder polyp: a survey among private clinicians in Korea.

Authors:  Jooyeon Jeong; Jae Keun Kim; Joon Seong Park; Dong Sup Yoon
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-05-31

10.  Engaging migrants and other stakeholders to improve communication in cross-cultural consultation in primary care: a theoretically informed participatory study.

Authors:  Christos Lionis; Maria Papadakaki; Aristoula Saridaki; Christopher Dowrick; Catherine A O'Donnell; Frances S Mair; Maria van den Muijsenbergh; Nicola Burns; Tomas de Brún; Mary O'Reilly de Brún; Evelyn van Weel-Baumgarten; Wolfgang Spiegel; Anne MacFarlane
Journal:  BMJ Open       Date:  2016-07-22       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.